Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 4/20 | 1.00 |
| ▸ | SLC22A2 | O15244 | 1/20 | 1.00 |
| ▸ | SLC22A1 | O15245 | 1/20 | 1.00 |
| ▸ | ABCG2 | Q9UNQ0 | 8/20 | 0.81 |
| ▸ | ABCB1 | P08183 | 5/20 | 0.81 |
| ▸ | ABCC1 | P33527 | 3/20 | 0.81 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.81 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.81 |
| ▸ | MEN1 | O00255 | 1/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.81 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.81 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.81 |
| ▸ | MAPT | P10636 | 2/20 | 0.65 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.65 |
| ▸ | TUBB | P07437 | 1/20 | 0.65 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.65 |
| ▸ | PKM | P14618 | 1/20 | 0.65 |
| ▸ | XDH | P47989 | 1/20 | 0.65 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15635199 | 0.91 | ADORA3 (0.83) | ADORA3SLC22A2SLC22A1ABCG2ABCB1 | |
| SCHEMBL30741221 | 0.91 | ADORA3 (1.00) | ADORA3SLC22A2SLC22A1ABCG2ABCB1 | |
| SCHEMBL1664287 | 0.91 | ADORA3 (1.00) | ADORA3SLC22A2SLC22A1ABCG2ABCB1 | |
| SCHEMBL20100901 | 0.90 | ADORA3 (0.81) | ADORA3SLC22A2SLC22A1ABCG2ABCB1 | |
| Pentamethylquercetin SCHEMBL30168919 | 0.90 | ABCG2 (1.00) | ADORA3SLC22A2SLC22A1ABCG2ABCB1 | |
| Pentamethylquercetin SCHEMBL2286327 | 0.90 | ABCG2 (1.00) | ADORA3SLC22A2SLC22A1ABCG2ABCB1 | |
| Pentamethylquercetin SCHEMBL30168918 | 0.90 | ABCG2 (1.00) | ADORA3SLC22A2SLC22A1ABCG2ABCB1 | |
| Pentamethylquercetin SCHEMBL29725289 | 0.90 | ABCG2 (1.00) | ADORA3SLC22A2SLC22A1ABCG2ABCB1 | |
| SCHEMBL20464068 | 0.88 | ADORA3 (1.00) | ADORA3SLC22A2SLC22A1ABCG2ABCB1 | |
| SCHEMBL29864461 | 0.88 | ADORA3 (1.00) | ADORA3SLC22A2SLC22A1ABCG2ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115248-A1 | METHOD FOR PRODUCING BLACK GINGER EXTRACT AND METHOD FOR PRODUCING COMPOSITION | MARUZEN PHARM CO LTD (JP) | 2026-04-30 | — | — | US | claimed |
| CN-114867486-B | Composition containing black ginger extract and composition for oral administration | 丸善制药株式会社 | 2023-05-30 | — | — | CN | claimed |
| US-20230021051-A1 | Composition Containing Black Ginger Extract and Composition for Oral Administration | MARUZEN PHARMACEUTICALS CO., LTD. (JP) | 2023-01-19 | — | — | US | claimed |
| US-20220346435-A1 | TOBACCO-DERIVED COMPOSITION | REYNOLDS TOBACCO CO R (US) | 2022-11-03 | — | — | US | claimed |
| CN-110432537-B | Tobacco-derived O-methylated flavonoid compositions | R.J.雷诺兹烟草公司 | 2022-08-19 | — | — | CN | claimed |
| CN-114867486-A | Composition containing Heijiang extract and oral composition | 丸善制药株式会社 | 2022-08-05 | — | — | CN | claimed |
| WO-2021131264-A1 | COMPOSITION CONTAINING BLACK GINGER EXTRACT AND COMPOSITION FOR ORAL ADMINISTRATION | 丸善製薬株式会社 | 2021-07-01 | — | — | WO | claimed |
| EP-2906055-B1 | METHOD OF EXTRACTING TOBACCO-DERIVED O-METHYLATED FLAVONOID AND USE THEREOF | REYNOLDS TOBACCO CO R (US) | 2020-12-16 | — | — | EP | claimed |
| CN-106455665-B | Black ginger oil extract and preparation method thereof | 三得利控股株式会社 | 2020-06-30 | — | — | CN | claimed |
| US-20180117000-A1 | ENERGY METABOLIC ACTIVATING AGENT FOR MUSCLE CELLS | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2018-05-03 | — | — | US | claimed |
| US-20170071902-A1 | NOX INHIBITOR AND NFkB INHIBITOR CONTAINING METHOXYFLAVONE | SUNTORY HOLDINGS LIMITED (JP) | 2017-03-16 | — | — | US | claimed |
| US-20170065509-A1 | FAT OR OIL EXTRACT OF BLACK GINGER AND METHOD FOR PRODUCING SAME | SUNTORY HOLDINGS LIMITED (JP) | 2017-03-09 | — | — | US | claimed |
| EP-2906055-A1 | TOBACCO-DERIVED O-METHYLATED FLAVONOID COMPOSITION | R. J. Reynolds Tobacco Company (US) | 2015-08-19 | — | — | EP | claimed |
| US-20140348961-A1 | SIRTUIN ACTIVATOR | Aburada, Masaki (JP) | 2014-11-27 | — | — | US | claimed |
| EP-2799081-A1 | SIRTUIN ACTIVATOR | Tokiwa Phytochemical Co., Ltd. (JP) | 2014-11-05 | — | — | EP | claimed |
| US-20140096780-A1 | TOBACCO-DERIVED COMPOSITION | R.J. REYNOLDS TOBACCO COMPANY (US) | 2014-04-10 | — | — | US | claimed |
| US-20260115248-A1 | METHOD FOR PRODUCING BLACK GINGER EXTRACT AND METHOD FOR PRODUCING COMPOSITION | MARUZEN PHARM CO LTD (JP) | 2026-04-30 | — | — | US | disclosed |
| CN-119837935-A | Pericarpium citri reticulatae extract with hair loss prevention and hair growth effects, and preparation method and application thereof | 广东邑祥陈皮有限公司 | 2025-04-18 | — | — | CN | disclosed |
| US-20020157939-A1 | Process for preparation of polyhydric alcohols | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2002-10-31 | — | — | US | disclosed |
| US-6066642-A | FOR SELECTIVELY BLOCKING THE A3 ADENOSINE RECEPTOR OF A MAMMAL | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2000-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115248-A1 | METHOD FOR PRODUCING BLACK GINGER EXTRACT AND METHOD FOR PRODUCING COMPOSITION | CYP4F8, CYP4F2, CYP4F11 | ADORA3 1764/4885SLC22A2 2815/4885SLC22A1 2585/4885 |
| US-20230021051-A1 | Composition Containing Black Ginger Extract and Composition for Oral Administration | CYP4F8, CYP4F2, CYP4F11 | ADORA3 2126/4885SLC22A2 1051/4885SLC22A1 761/4885 |
| US-20170065509-A1 | FAT OR OIL EXTRACT OF BLACK GINGER AND METHOD FOR PRODUCING SAME | FABP4, PLIN5, FABP6 | ADORA3 3949/4885SLC22A2 1571/4885SLC22A1 1677/4885 |
| US-20180117000-A1 | ENERGY METABOLIC ACTIVATING AGENT FOR MUSCLE CELLS | SLC2A1, SLC2A2, SLC2A4 | ADORA3 1129/4885SLC22A2 115/4885SLC22A1 101/4885 |
| US-20170071902-A1 | NOX INHIBITOR AND NFkB INHIBITOR CONTAINING METHOXYFLAVONE | NOX1, NFKBIA, NOX5 | ADORA3 4826/4885SLC22A2 4124/4885SLC22A1 3939/4885 |
| US-20020157939-A1 | Process for preparation of polyhydric alcohols | ADH1C, ADH1A, ADH5 | ADORA3 1693/4885SLC22A2 4547/4885SLC22A1 4614/4885 |
| US-20140348961-A1 | SIRTUIN ACTIVATOR | SIRT1, HDAC1, SIRT2 | ADORA3 1184/4885SLC22A2 2483/4885SLC22A1 2073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.